Cargando…
Galectin-3 Involvement in Cognitive Processes for New Therapeutic Considerations
Cognitive impairment may be a consequence of the normal aging process, but it may also be the hallmark of various neurodegenerative and psychiatric diseases. Early identification of individuals at particular risk for cognitive decline is critical, as it is imperative to maintain a cognitive reserve...
Autores principales: | Mijailović, Nataša R., Vesic, Katarina, Arsenijevic, Dragana, Milojević-Rakić, Maja, Borovcanin, Milica M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296991/ https://www.ncbi.nlm.nih.gov/pubmed/35875353 http://dx.doi.org/10.3389/fncel.2022.923811 |
Ejemplares similares
-
Targeting Underlying Inflammation in Carcinoma Is Essential for the Resolution of Depressiveness
por: Borovcanin, Milica M., et al.
Publicado: (2023) -
Galectin-3 possible involvement in antipsychotic-induced metabolic changes of schizophrenia: A minireview
por: Borovcanin, Milica M, et al.
Publicado: (2021) -
The Influence of Serum Uric Acid on the Brain and Cognitive Dysfunction
por: Mijailovic, Natasa R., et al.
Publicado: (2022) -
Neuroimmune, clinical and treatment challenges in multiple sclerosis-related psychoses
por: Vesic, Katarina, et al.
Publicado: (2023) -
Uric Acid Potential Role in Systemic Inflammation and Negative Symptoms After Acute Antipsychotic Treatment in Schizophrenia
por: Borovcanin, Milica M., et al.
Publicado: (2022)